BriaCell Therapeutics Cor...

NASDAQ: BCTX · Real-Time Price · USD
0.74
0.00 (0.14%)
At close: Aug 15, 2025, 3:59 PM
0.72
-2.70%
After-hours: Aug 15, 2025, 07:39 PM EDT

BriaCell Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is August - July.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jul 31, 2024 Jul 31, 2023 Jul 31, 2022 Jul 31, 2021
Cash & Equivalents
862.09K 21.25M 41.04M 57.27M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
418.49K 2.00 2.00 2.00
Other Long-Term Assets
1.21M 0.00 0.00 0.00
Receivables
1.37M 717.74K 24.1K 12.57K
Inventory
n/a 5.67M n/a 516.23K
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
3.65M 26.95M 42.35M 57.8M
Property-Plant & Equipment
388.18K n/a n/a n/a
Goodwill & Intangibles
199.8K 215.07K 230.34K 245.61K
Total Long-Term Assets
2.22M 215.07K 230.34K 245.61K
Total Assets
5.87M 27.16M 42.58M 58.04M
Account Payables
7.17M 1.12M 463.28K 214.12K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
n/a n/a n/a n/a
Total Current Liabilities
7.46M 1.8M 941.09K 556.79K
Long-Term Debt
n/a n/a n/a 25.99K
Other Long-Term Liabilities
1.1M 29.14M 31.31M 199.46K
Total Long-Term Liabilities
1.1M 29.14M 31.31M 225.44K
Total Liabilities
8.56M 30.94M 32.25M 782.24K
Total Debt
n/a n/a n/a 25.99K
Common Stock
72.17M 69.59M 65.59M 54.78M
Retained Earnings
-85.48M -80.65M -60.35M -15.75M
Comprehensive Income
-138.68K -138.68K -138.68K -138.68K
Shareholders Equity
-2.38M -3.78M 10.33M 57.26M
Total Investments
418.49K 2.00 2.00 2.00